Dardik H, Ibrahim I M, Baier R, Sprayregen S, Levy M, Dardik I I
JAMA. 1976 Dec 20;236(25):2859-62. doi: 10.1001/jama.236.25.2859.
Reconstructions were performed to the popliteal, tibial, and peroneal arteries employing a modified umbilical cord vein prosthesis. The latter was obtained from human cords and was made available as an onshelf graft for surgery following glutaraldehyde tanning. The early patency and limb salvage rates are equivalent to those obtained with autogenous saphenous veins. Additional benefits include significant decreased operative time and morbidity. It is also probable that this new graft may be resistant to biodegradation and therefore may obviate many of the causes for late failure that occur with the use of living biologic tissues or collagen tubes. Long-term follow-up and study are essential to validate the results obtained thus far and to assess the potential of this new graft in a variety of vascular reconstructions.
采用改良的脐带静脉假体对腘动脉、胫动脉和腓动脉进行重建。后者取自人脐带，经戊二醛鞣制后作为现成的移植物用于手术。早期通畅率和肢体挽救率与自体隐静脉相当。其他优点包括手术时间和发病率显著降低。这种新的移植物也可能具有抗生物降解性，因此可能消除使用活生物组织或胶原管时发生晚期失败的许多原因。长期随访和研究对于验证目前获得的结果以及评估这种新移植物在各种血管重建中的潜力至关重要。
